The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema

Pauline T. Merrill,Nancy Holekamp,Daniel Roth,Jonathan Kasper,Ruben Grigorian

American Journal of Ophthalmology（2022）

引用 2|浏览5

暂无评分

摘要

Over 36 months, the FAc implant is associated with improved visual outcomes and better disease control as measured by a significant reduction in yearly treatment burden in patients with DME.

查看译文

关键词

diabetic macular edema

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要